Preclinical Results And The Distance To People

The majority of published research on Ayurvedic botanicals is laboratory or animal work. The distance between that kind of finding and a demonstrated human benefit is longer than most summaries suggest.

What preclinical research consists of

Cell studies apply an extract or compound to cultured cells and measure a change, which establishes that the substance can affect that system under those conditions.

Animal studies test in a whole organism, adding absorption, distribution and metabolism to the picture, usually in rodents and usually over short periods.

Both are legitimate and necessary stages, and both are far cheaper and faster than human trials, which is why they dominate the published output.

Why concentration is the first problem

Compounds are frequently applied to cells at concentrations far above anything achievable in a person's bloodstream after swallowing the plant.

Absorption is often poor for the plant compounds that look most interesting, and many are extensively modified by the gut and liver before reaching circulation.

A finding that a compound does something in a dish therefore says nothing about whether the relevant tissue ever encounters enough of it.

Why animal models translate imperfectly

Animal models of human disease reproduce some features and not others, and a model of inflammation in a mouse is not the same as a chronic condition in a person.

Dose scaling between species is not straightforward, and metabolic differences mean the compounds circulating after a dose may differ between animals and humans.

Across drug development generally, the majority of compounds that succeed in animals fail in human trials, which is the base rate any preclinical result sits against.

How this shapes claims about herbs

Marketing frequently cites laboratory findings about antioxidant or anti-inflammatory activity, which are the easiest results to generate and the least informative.

The same claims can usually be made about many ordinary foods, since these assays return positive results for a very wide range of plant material.

Presenting such findings as evidence that a product works in people is a category error, whether or not it is made deliberately.

What to look for instead

The useful question is whether human trials exist, how many people they included, how long they ran and what they measured.

Where only preclinical evidence exists, the honest description is that a plant is of scientific interest and untested in people for the claimed use.

Treatment decisions for any diagnosed condition require human evidence and a physician, and laboratory findings do not substitute for either.